Search
for
Sort by
Research 121–150 of 423
- High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Androgens in women
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Polycystic ovary syndrome: A review for dermatologists
- Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications
- Androgen antagonists in androgen target tissues
- Hormonal therapies for acne
- Association of metabolic syndrome with female pattern hair loss in women: A case-control study
- Skin signs of systemic diseases
- The endocrinology of baldness
- Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Sulforaphane promotes murine hair growth by accelerating the degradation of dihydrotestosterone
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Dermatosis associated with menopause
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Treatment of hyperandrogenism in women
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The role of androgens in hormone replacement therapy
- Spironolactone May Reduce the Risk of Incident Rosacea
- Endocrine disorders and hormonal therapy for adolescent acne
- Acne
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life